Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 800 of 866 entries
View as:

A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China

Phase: N/A Priority: Normal
NCT ID: NCT03236870 Org: User:
Start: 09/08/17 End: 08/25/20 Due: 08/25/21

Study To Assess Effectiveness and Adverse Events of Foscarbidopa/ Foslevodopa in Adult Participants With Advanced Parkinson Disease in Real Life Setting

Phase: N/A Priority: Normal
NCT ID: NCT06639620 Org: User:
Start: 11/12/24 End: 03/31/27 Due: 03/31/28

A Study of the Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in Patients With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03941964 Org: User:
Start: 08/15/19 End: 03/14/22 Due: 03/14/23

Assessment of the Safety of Adalimumab in Rheumatoid Arthritis Patients Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying Anti-rheumatic Drugs or Biological Agents

Phase: N/A Priority: Normal
NCT ID: NCT01783730 Org: User:
Start: 02/28/13 End: 09/30/15 Due: 09/30/16

A Study in Healthy Japanese and Caucasian Subjects to Assess the Pharmacokinetics, Safety and Tolerability of Risankizumab

Phase: N/A Priority: Normal
NCT ID: NCT05305222 Org: User:
Start: 10/23/17 End: 06/15/18 Due: 06/15/19

A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)

Phase: N/A Priority: Normal
NCT ID: NCT04880876 Org: User:
Start: 08/13/21 End: 03/15/27 Due: 03/15/28

Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT04352309 Org: User:
Start: 05/29/20 End: 06/11/21 Due: 06/11/22

A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03924323 Org: User:
Start: 05/30/19 End: 09/20/21 Due: 09/20/22

Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT02616380 Org: User:
Start: 11/05/15 End: 11/23/17 Due: 11/23/18

A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)

Phase: N/A Priority: Normal
NCT ID: NCT05029895 Org: User:
Start: 09/29/21 End: 03/31/26 Due: 03/31/27

A Study to Assess Patient-Reported Quality of Life and Effectiveness on Control of Bleeding in Adult Participants With Heavy Menstrual Bleeding Due to Uterine Fibroids Taking Oral Oriahnn Capsules

Phase: N/A Priority: Normal
NCT ID: NCT05026502 Org: User:
Start: 10/05/21 End: 08/30/22 Due: 08/30/23

A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00654758 Org: User:
Start: 12/31/07 End: 05/31/10 Due: 05/31/11

An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease

Phase: N/A Priority: Normal
NCT ID: NCT05757141 Org: User:
Start: 03/13/23 End: 11/30/29 Due: 11/30/30

Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine

Phase: N/A Priority: Normal
NCT ID: NCT05748483 Org: User:
Start: 10/07/23 End: 05/31/26 Due: 05/31/27

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT06428019 Org: User:
Start: 08/05/24 End: 12/31/26 Due: 12/31/27

A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT04430855 Org: User:
Start: 07/14/20 End: 01/25/22 Due: 01/25/23

Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)

Phase: N/A Priority: Normal
NCT ID: NCT02533375 Org: User:
Start: 09/28/15 End: 07/20/17 Due: 07/20/18

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Phase: N/A Priority: Normal
NCT ID: NCT04686786 Org: User:
Start: 12/08/20 End: 12/05/24 Due: 12/05/25

Expanded Access to Telisotuzumab Adizutecan

Phase: N/A Priority: Normal
NCT ID: NCT05982873 Org: User:
Start: - End: - Due: -

A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT05227703 Org: User:
Start: 06/30/22 End: 09/11/24 Due: 09/11/25

A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT04285580 Org: User:
Start: 06/11/20 End: 05/14/22 Due: 05/14/23

A Study to Assess Adverse Events and Change of Masseter Muscle Prominence Using BOTOX Injections in Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06137287 Org: User:
Start: 11/22/23 End: 01/10/26 Due: 01/10/27

A Study to Evaluate the Safety and Tolerability of Venetoclax Tablets in Combination With Capecitabine Tablets in Adult Participants With Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Had Disease Progression During or After CDK4/6 Inhibitor Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04274933 Org: User:
Start: 05/21/20 End: 10/08/20 Due: 10/08/21

A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT02292719 Org: User:
Start: 12/19/14 End: 07/14/17 Due: 07/14/18

A Study of Viekira/Exviera for Korean Hepatitis C Patients According to the Standard for Re-examination of New Drugs

Phase: N/A Priority: Normal
NCT ID: NCT03201718 Org: User:
Start: 08/17/17 End: 10/11/19 Due: 10/11/20